The Evidence Backing Your Recommendation

Easily Refer Your Patient Today

Redefining the EECP® Patient Experience

Flow Therapy is advancing the EECP patient experience by pairing treatments with comprehensive education for chronic conditions including medication reconciliation.

Patient Types Who Can Benefit from Flow Therapy

Optimizing Medical Therapy
Post-Cath
INOCA / Microvascular
Heart Failure

Hello, I’m Frank, I’m a 79-year-old male with DM, CKD, and PAD. I am an ischemic cardiomyopathy patient with reduced LV function, and have an AICD. I’ve had a previous MI and CABGx2 years ago and now with failed grafts.

I’ve had 3 trips to the hospital last year, and I severely limit my activities to avoid dyspnea and fatigue. I am on maximal tolerated medication with a blood pressure of 100/72.

Doctor, I would like Flow Therapy.
High Risk

What Is Flow Therapy?

In the span of 35 hour-long EECP treatments delivered over 7 weeks, Flow Therapy makes a lasting difference in patients facing limitations associated with heart disease. Patients lie on a treatment table where compressive cuffs (similar to large blood pressure cuffs) are securely wrapped around their calves, thighs, and buttocks.

These cuffs inflate in a distal to proximal sequence during diastole, and deflate simultaneously just prior to the onset of systole. Inflation and deflation are specifically timed to the patient’s ECG to optimize therapeutic benefit.

The sequential cuff inflation creates a retrograde pressure wave that augments diastolic pressure, increasing coronary perfusion pressure and venous return to the right heart (increasing preload and cardiac output). Rapid and simultaneous cuff deflation decreases systemic vascular resistance, afterload, and cardiac workload.

Flow Therapy Facts & Outcomes

Examine Clinical Outcomes

Every year, we perform more than 40,000 EECP treatments.
88% of patients see significant improvements using validated markers.
1,000+ referring providers trust Flow Therapy centers to improve their patients.
We’ve earned a 91 Net Promoter Score (customer satisfaction).
There are 400+ clinical studies proving the efficacy and safety of EECP.
Practiced by cardiovascular leaders like Cleveland Clinic and Mayo Clinic.